Cargando…
Long-term outcomes of epoprostenol therapy in sarcoid associated pulmonary hypertension
Sarcoidosis-Associated Pulmonary Hypertension (SAPH) is a common finding in patients with chronic sarcoidosis and is associated with increased mortality. The optimal treatment for SAPH is not known; however, therapies approved for Group 1 pulmonary hypertension have improved hemodynamics and functio...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Mattioli 1885
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569545/ https://www.ncbi.nlm.nih.gov/pubmed/33093782 http://dx.doi.org/10.36141/svdld.v37i2.9150 |